Option Care — первая национальная компания, предлагающая услуги по проведению инфузионной терапии на дому, получившая аккредитацию PCAB (Совета по аккредитации рецептурных аптек США) для всех рецептурных аптек
By: Option Care
October 3, 2017
BANNOCKBURN, Ill., Oct. 3, 2017 — Option Care Enterprises, Inc., one of the leading providers of home and alternate treatment site infusion therapy services, is the first national home infusion company to achieve accreditation at each of its compounding pharmacies by the Pharmacy Compounding Accreditation Board (PCAB). This ensures they meet or exceed the most rigorous standards.
The accreditation verifies all Option Care cleanroom pharmacies — in which sterile compounding of intravenous (IV) medications for specific physician orders is performed — meet the highest-level standards, far and above what is required in most states. A service of Accreditation Commission for Health Care (ACHC), PCAB accreditation offers the most comprehensive compliance solution in the industry based on more than 40 sterile compounding standards in the U.S. Pharmacopeial Convention (USP) guidelines, or USP 797.
Ранее Option Care уже прошла аккредитацию ACHC, присуждаемую организациям здравоохранения, отвечающим нормативным требованиям и стандартам аккредитации. Теперь все наши производственные аптеки прошли аккредитацию PCAB, подтверждая наше стремление к высокому качеству работы и соответствию наивысшим стандартам.
“PCAB accreditation of all of our compounding pharmacies provides an objective, external validation of our commitment to quality,” said Brenda Wright, Vice President of Clinical Services, Option Care. “Going above and beyond what is required is what we do. It’s how we approach our clinical services from the perspective of total quality management. This accreditation speaks to our pledge to drive continuous quality improvement and provide optimal outcomes for our patients.”
Аккредитация PCAB — это комплексный аудит аптеки, который проводится независимым экспертом на месте с целью проверки соответствия требованиям к смешиванию нестерильных и стерильных лекарственных препаратов, предусмотренным фармакопейными статьями USP 795 и USP 797. Организация ACHC отмечает, что аккредитация PCAB в сочетании со стремлением аптеки постоянно работать над качеством услуг, значительно сокращает риски, связанные с использованием составных препаратов, и подтверждает намерение соответствовать высочайшим отраслевым стандартам качества и безопасности.
“We are thrilled that Option Care has chosen to leverage the breadth of pharmacy accreditation programs ACHC offers,” said José Domingos, CEO of ACHC. “This demonstrates a commitment to delivering quality care for patients.”
До аккредитации PCAB все корпоративные аптеки и три специализированных фармацевтических центра Option Care прошли аккредитацию для специализированных аптек URAC с высочайшим баллом 100 %.
Об организации ACHC
ACHC is a non-profit organization that has stood as a symbol of quality and excellence since 1986. ACHC is the provider’s choice for compliance solutions because of its personal Account Advisors, relevant and realistic standards, competitive pricing, and a friendly, consultative approach to accreditation. Beginning July 2014, PCAB became a service of ACHC, offering programs for non-sterile (ref. USP 795) and sterile (ref. USP 797) compounding services. PCAB assesses the compounding process based on a specific set of standards that concentrate on the quality and consistency of compounded medications while incorporating performance improvement and ongoing compliance requirements. PCAB Accreditation reflects an organization’s dedication and commitment to meeting standards that facilitate a higher level of performance and patient care. For more information on ACHC’s accreditation programs and educational resources, or to download ACHC accreditation standards, visit www.achc.org.
О компании Option Care
Option Care Enterprises, Inc. (Option Care) is one of the nation’s largest and most trusted providers of home and alternate treatment site infusion services. An industry leader, the company draws on nearly 40 years of clinical care experience to offer patient-centered therapy management. Option Care’s signature Home Infusion Plus services include the clinical management of infusion medicines, nursing support and care coordination. Option Care’s multidisciplinary team of more than 1,800 clinicians — including pharmacists, nurses and dietitians — are able to provide home infusion service coverage for nearly all patients across the United States needing treatment for complex and chronic conditions. Learn more at www.OptionCare.com.
You might also be interested in:
Option Care Selected as the Home and Alternate Site Infusion Provider for Newly Approved Breakthrough Therapy, Trogarzo (ibalizumab-uiyk) Injection
BANNOCKBURN, Ill., March 9, 2018 — Option Care Enterprises, Inc., the nation’s largest independent provider of home and alternate treatment site infusion services, has been selected by Theratechnologies Inc. as an infusion provider for TrogarzoTM (ibalizumab-uiyk) Injection, an intravenous (IV) infusion for the treatment of multidrug resistant human immunodeficiency virus type 1 (HIV-1) infections. Option […]
По данным исследования Option Care пациенты с сердечной недостаточностью, проходящие инотропную инфузионную терапию на дому, имеют более высокое качество жизни
Patients Benefitted Significantly Overall, According to Results Presented at NHIA Meeting BANNOCKBURN, Ill., July 12, 2017 — Advanced heart failure patients who receive home infusion of inotropic therapy benefit from improved quality of life, according to Option Care research presented at the 2017 National Home Infusion Association (NHIA) Annual Conference & Exposition. Patients with advanced […]